ARK shifts to CoreWeave and Twist Bioscience, trims Amazon and Palantir

uk.investing.com —

Cathie Wood’s ARK ETFs made major trades on Thursday, November 12, 2026, buying CoreWeave and Twist Bioscience while selling Amazon and Palantir stock. ARK purchased 283,022 CoreWeave shares worth $17.2 million and 72,834 Twist Bioscience shares for $8.9 million. It sold 15,941 Amazon shares valued at $4.2 million and 58,339 Palantir shares totaling $10.1 million. ARK also bought shares in Archer Aviation, Kratos Defense, Rocket Lab, and Scribe Therapeutics, while reducing positions in BYD and Tempus AI. These moves reflect a shift toward cloud infrastructure and biotech.


With a significance score of 1.4, this news ranks in the top 38% of today's 31735 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: